Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sex steroids and the cardiovascular system.

Literature DB >> 9205639

Sex steroids and the cardiovascular system.

Abstract

HRT decreases significantly the risk of cardiovascular disease in postmenopausal women. More and more data indicate that this is true not only for unopposed oestrogen but also for combined oestrogen/progestin therapy. The latter point is of utmost importance since the global treatment strategy for women with an intact uterus includes a progestin.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1997 PMID： 9205639 DOI： 10.1007/bf01674806

Source DB: PubMed Journal: Osteoporos Int ISSN： 0937-941X Impact factor: 4.507

30 in total

1. The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women.

Authors: S G Thompson; T W Meade; G Greenberg
Journal: J Epidemiol Community Health Date: 1989-06 Impact factor: 3.710

Review 2. Dyslipoproteinemia in women. Special considerations.

Authors: V T Miller
Journal: Endocrinol Metab Clin North Am Date: 1990-06 Impact factor: 4.741

3. The effects of conjugated equine oestrogens with and without a cyclical progestogen on lipoproteins, and HDL subfractions in postmenopausal women.

Authors: E Farish; C D Fletcher; D M Hart; H T Teo; F Alazzawi; C Howie
Journal: Acta Endocrinol (Copenh) Date: 1986-09

Sex steroids and the cardiovascular system.

1. The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women.

Review 2. Dyslipoproteinemia in women. Special considerations.

3. The effects of conjugated equine oestrogens with and without a cyclical progestogen on lipoproteins, and HDL subfractions in postmenopausal women.

4. Meaning of a modified LDL in humans.

5. Estrogen replacement therapy and hypertension.

6. Postmenopausal estrogen use and coronary atherosclerosis.

7. Risk factors and noncontraceptive estrogen use in women with and without coronary disease.

8. Estrogen modulates responses of atherosclerotic coronary arteries.

9. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.

10. Natural oestrogen as an effective treatment for type-II hyperlipoproteinaemia in postmenopausal women.

1. Antiatherogenic properties of acetone extract of Alpinia zerumbet seeds.